Summary
- Current Price
- As of today, TRAX price is $44.50, up +2.13% on
- Current Price All-Time High
- TRAX price is currently -18.77% below its historical high of $54.78 set on
- Market Cap
- TRAX current market cap is $2B
- Revenue
- TRAX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for TRAX is on
Profile
| Metric | Value |
|---|---|
| Full Name | First Tracks Biotherapeutics, Inc. |
| Ticker | NASDAQ: TRAX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | firsttracksbio.com |
| Employees | 104 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $44.50 | |
| Price, 1D Change | +2.13% | |
| $2B | ||
| - | ||
| - | ||
| 2.37 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$4.76 | ||
| EPS, 1Y Change | -1.46% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | TRAXV | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$4.76 | ||
| EPS Estimate | -$3.87 | |
| EPS Est. Change | +18.75% | |
| $0.00 | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $44.50 | |
| Price Target | $70.00 | - |
| Price Tgt. Change | +57.30% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$4.69 | - | |
| - | -$4.76 | - | |
| -$3.87 | N/A | +18.75% | |
| -$3.46 | N/A | +27.26% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $44.50 | |
| $31.90 | ||
| $40.16 | ||
| - | ||
| $42.12 | ||
| $1.84 | ||
| 2.37 | ||
| $3.21 | ||
| 50.22 | ||
| 75.06% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$4.76 | ||
| -$2.42M | ||
| - | ||
| -$179.01M | ||
| - | ||
| -$166.09M | ||
| - | ||
| -$176.58M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.05 | ||
| 10.20 | ||
| 10.20 | ||
| - | ||
| - | ||
| 25.31 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 12.38 | ||
| -14.40 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $287.49M | ||
| $311.64M | ||
| $330.55M | ||
| $316.40M | ||
| $43.06M | ||
| $31.02M | ||
| $14.11M | ||
| $2.08M | ||
| $3.11M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $166.09M | ||
| $176.58M | ||
| $2.42M | ||
| $39.39M | ||
| $2.42M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$142.93M | ||
| $228.03M | ||
| $30.01M | ||
| $87.00K | ||
| -$143.01M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Guggenheim | → | |
| Leerink Partners | → | |
| Wells Fargo | → | |
| Evercore ISI Group | → | |
| Canaccord Genuity | → | |
| Canaccord Genuity | ||
| Evercore ISI Group | ||
| Guggenheim | ||
| HC Wainwright & Co. | → | |
| Wedbush | → |
Analyst sentiment
Institutional ownership
Screeners with TRAX
FAQ
- What is the ticker symbol for First Tracks Biotherapeutics, Inc.?
- The ticker symbol for First Tracks Biotherapeutics, Inc. is NASDAQ:TRAX
- Does First Tracks Biotherapeutics, Inc. pay dividends?
- No, First Tracks Biotherapeutics, Inc. does not pay dividends
- What sector is First Tracks Biotherapeutics, Inc. in?
- First Tracks Biotherapeutics, Inc. is in the Healthcare sector
- What industry is First Tracks Biotherapeutics, Inc. in?
- First Tracks Biotherapeutics, Inc. is in the Biotechnology industry
- What country is First Tracks Biotherapeutics, Inc. based in?
- First Tracks Biotherapeutics, Inc. is headquartered in United States
- When did First Tracks Biotherapeutics, Inc. go public?
- First Tracks Biotherapeutics, Inc. initial public offering (IPO) was on April 20, 2026
- Is First Tracks Biotherapeutics, Inc. in the S&P 500?
- No, First Tracks Biotherapeutics, Inc. is not included in the S&P 500 index
- Is First Tracks Biotherapeutics, Inc. in the NASDAQ 100?
- No, First Tracks Biotherapeutics, Inc. is not included in the NASDAQ 100 index
- Is First Tracks Biotherapeutics, Inc. in the Dow Jones?
- No, First Tracks Biotherapeutics, Inc. is not included in the Dow Jones index
- When was First Tracks Biotherapeutics, Inc. last earnings report?
- First Tracks Biotherapeutics, Inc.'s most recent earnings report was on November 3, 2026
- When does First Tracks Biotherapeutics, Inc. report earnings?
- The next expected earnings date for First Tracks Biotherapeutics, Inc. is February 23, 2027
Data Sources & References
- TRAX Official Website www.firsttracksbio.com
- TRAX Profile on Yahoo Finance finance.yahoo.com/quote/TRAX
- TRAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/trax